Palatin Technologies, Inc.Palatin Technologies, Inc.Palatin Technologies, Inc.

Palatin Technologies, Inc.

No trades
See on Supercharts

Palatin Technologies, Inc. stock forum


PTN
Palatin (PTN) is flying under the radar, but it’s about to explode. Here’s why:

🔑 Catalysts for massive upside:

Bremelanotide (PTN’s lead drug) is advancing through FDA stages.

Major pharma partnerships are forming.

M&A potential – PTN could be a buyout target.

💰 Price Targets:
– Short-term: $3.50
– Mid-term (2025): $7.50–$10.00

Don’t miss out – this is a game-changer.

📩 Reach out via Telegram: ( i. v. a. n. p. a. t. r. i. c. e )